Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Peyrat

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Cancer Letters|October 8, 1990
Diffusion of insulin-like growth factor 1 in human breast cancer explantsB Hecquet, J P Peyrat
Breast Cancer Research and Treatment|January 1, 1992
Type 1 IGF receptor in human breast diseasesJ P Peyrat, J Bonneterre
The International Journal of Biological Markers|April 14, 2000
Significance of soluble endothelial molecule E-selectin in patients with breast cancerM Hebbar, J P Peyrat
Bulletin Du Cancer|January 1, 1987
[Determination of estradiol and progesterone receptors in breast cancer. Determination by Scatchard's method or by a single point test]J P Peyrat, J Fournier
European Journal of Cancer & Clinical Oncology|July 1, 1989
Prolactin receptors (PRL-R) and breast cancerJ Bonneterre, J P Peyrat
Anticancer Research|May 1, 1989
Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D)B Leroy-Martin, J P Peyrat
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
ERBB2 oncogene in human breast cancer and its clinical significanceF Révillion, J Bonneterre, J P Peyrat
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
Growth factors and oncogenes in human solid tumors: clinical aspectsJ Bonneterre, J P Peyrat, A Demaille
Clinical Chemistry|November 20, 1997
Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCRF Révillion, L Hornez, J P Peyrat
British Journal of Cancer|July 4, 1998
Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapyJ P Peyrat, F Révillion, J Bonneterre
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Cancer Letters|October 8, 1990
Diffusion of insulin-like growth factor 1 in human breast cancer explantsB Hecquet, J P Peyrat
Breast Cancer Research and Treatment|January 1, 1992
Type 1 IGF receptor in human breast diseasesJ P Peyrat, J Bonneterre
The International Journal of Biological Markers|April 14, 2000
Significance of soluble endothelial molecule E-selectin in patients with breast cancerM Hebbar, J P Peyrat
Bulletin Du Cancer|January 1, 1987
[Determination of estradiol and progesterone receptors in breast cancer. Determination by Scatchard's method or by a single point test]J P Peyrat, J Fournier
European Journal of Cancer & Clinical Oncology|July 1, 1989
Prolactin receptors (PRL-R) and breast cancerJ Bonneterre, J P Peyrat
Anticancer Research|May 1, 1989
Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D)B Leroy-Martin, J P Peyrat
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
ERBB2 oncogene in human breast cancer and its clinical significanceF Révillion, J Bonneterre, J P Peyrat
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
Growth factors and oncogenes in human solid tumors: clinical aspectsJ Bonneterre, J P Peyrat, A Demaille
Clinical Chemistry|November 20, 1997
Quantification of c-erbB-2 gene expression in breast cancer by competitive RT-PCRF Révillion, L Hornez, J P Peyrat
British Journal of Cancer|July 4, 1998
Plasma insulin-like growth factor in primary breast cancer patients treated with adjuvant chemotherapyJ P Peyrat, F Révillion, J Bonneterre
Pageof 10